Radiotherapy after D2 Lymph Node Dissection +/- Omentectomy in Gastric Cancer | Asian Journal of...

The goal of the review is to look at the indications for radiotherapy in stomach cancer and the places where it can be used. Gastric cancer is the fifth most frequent cancer in the world and the third leading cause of cancer mortality. It is a sneaky disease that is usually asymptomatic until it has progressed to an advanced stage. Surgical treatment is still the gold standard, notwithstanding recent advances in chemotherapy, radiation, and immunotherapy. The lymph nodes of the stomach are divided into 16 groups and categorised from N1 to N3 based on their location. Lymph node dissections are separated from D0 to D3 in the same order as lymph nodes. D0 dissection means that no lymph nodes from the N1 group were dissected; D1 dissection dissolves the entire N1; D2 dissection indicates that all lymph nodes from the N1 and N2 groups were dissected; D3 dissection indicates that all lymph nodes from the N1, N2, and N3 groups were dissected. Gastric cancer has a bad prognosis and is an aggressive cancer, according to the findings. Surgery is the main treatment. Total / partial gastrectomy + D1 (+/-) D2 lymph node dissection +/- omentectomy is the surgical treatment. Postoperative irradiation for D2 dissected +/- omentectomy gastric cancer, the importance of RT in treatment, the goal volume of RT, innovative RT approaches to limit potential toxicity, and which group of patients is unclear is unclear. The findings of a prospective randomised trial will be more reliable.

Please see the link :- https://globalpresshub.com/index.php/AJRMMS/article/view/726